Voyager Acquisition Corp Class A Ordinary Shares
$17.27
USD
Last updated on --.
24h volume12.44K
24h highest17.4199 USD
24h lowest13.1700 USD
24h Price movement+0.91%


VACH recent prices
24 Hours
+0.91%+$0.155
30 days
+70.32%+$7.130
60 days
+38.05%+$4.760
90 days
+63.70%+$6.720
Key data
Previous close17.1147 USD
Market cap335.23M USD
Volume12.44K
P/E ratio43.660000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)0.24000 USD
Net income (FY)6.74M USD
Revenue (FY)--
Last report dateMay 20, 2026
About Voyager Acquisition Corp Class A Ordinary Shares
HeadquartersHOUSTON
Employees (FY)3.00
Net income per employee (FY)2.25M USD
Listed onNasdaq
VACH conversion tables
| 0.5 VACH | 8.635 USD |
| 1 VACH | 17.27 USD |
| 5 VACH | 86.35 USD |
| 10 VACH | 172.7 USD |
| 0.5 USD | 0.028952 VACH |
| 1 USD | 0.057904 VACH |
| 5 USD | 0.28952 VACH |
| 10 USD | 0.57904 VACH |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
VACH is trading at $17.27, +0.91% over the last 24 hours. Track live moves on the price chart at the top of this page.
The VACH stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. VACH is currently trading at $17.27, +0.91% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on VACH price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. VACH's P/E ratio is currently 43.660000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from VACH; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against VACH's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Voyager Acquisition Corp Class A Ordinary Shares's market cap is currently 335.23M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume12.44K
24h highest17.4199 USD
24h lowest13.1700 USD
24h Price movement+0.91%


Start trade with VACH Perpetual
Sign up to trade














